Literature DB >> 28554722

Common clinical features of CF (respiratory disease and exocrine pancreatic insufficiency).

Ranjani Somayaji1, Kathleen J Ramos2, Siddhartha G Kapnadak2, Moira L Aitken2, Christopher H Goss3.   

Abstract

First described as a disease of the pancreas, cystic fibrosis is a genetically inherited progressive disease affecting multiple organ systems. Pulmonary and pancreatic involvement is common in individuals with cystic fibrosis, and the former is attributable to most of the mortality that occurs with the condition. This chapter provides an overview of a clinical approach to the pulmonary and pancreatic manifestations of cystic fibrosis.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28554722     DOI: 10.1016/j.lpm.2017.03.021

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  4 in total

Review 1.  Molecular mechanisms of cystic fibrosis - how mutations lead to misfunction and guide therapy.

Authors:  Carlos M Farinha; Isabelle Callebaut
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

2.  Standardized clinical criteria and sweat test combined as a tool to diagnose Cystic Fibrosis.

Authors:  Fabricio González-Andrade
Journal:  Heliyon       Date:  2018-12-17

3.  Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis.

Authors:  Silvia Lai; Sandro Mazzaferro; Anna Paola Mitterhofer; Enea Bonci; Paolo Giangreco Marotta; Francesco Pelligra; Manuel Murciano; Camilla Celani; Patrizia Troiani; Giuseppe Cimino; Paolo Palange
Journal:  J Transl Med       Date:  2019-11-25       Impact factor: 5.531

Review 4.  Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine.

Authors:  Lăcrămioara Ionela Butnariu; Elena Țarcă; Elena Cojocaru; Cristina Rusu; Ștefana Maria Moisă; Maria-Magdalena Leon Constantin; Eusebiu Vlad Gorduza; Laura Mihaela Trandafir
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.